Screener
Madrigal Pharmaceuticals, Inc. MDGL Operating Lease Liabilities (Total)
Discontinued — last reported Q4 '25
Operating Lease Liabilities (Total) at other companies
Segments
By geography
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The source filing: Madrigal Pharmaceuticals, Inc.’s 10-K, filed February 19, 2026.
- Filed
- Feb 19, 2026, 9:09 AM EST
- Fiscal year
- FY2025
- Accession
- 0001628280-26-009514
FAQ
- What is Madrigal Pharmaceuticals, Inc.'s operating lease liabilities (total)?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported operating lease liabilities (total) of $7.75M in Q4 2025.
- How has Madrigal Pharmaceuticals, Inc.'s operating lease liabilities (total) changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s operating lease liabilities (total) increased by 287.3% year-over-year, from $2M to $7.75M.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s operating lease liabilities (total)?
- Over 5 years (2020 to 2025), Madrigal Pharmaceuticals, Inc.'s operating lease liabilities (total) has grown at a 58.0% compound annual growth rate (CAGR), from $786K to $7.75M.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.
Ask your AI about Madrigal Pharmaceuticals, Inc.'s operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude